{"id":"https://openalex.org/W2321746654","doi":"https://doi.org/10.1007/s00262-016-1829-2","title":"4-1BB agonism: adding the accelerator to cancer immunotherapy","display_name":"4-1BB agonism: adding the accelerator to cancer immunotherapy","alternate_titles":[],"publication_year":2016,"publication_date":"2016-03-31","ids":{"openalex":"https://openalex.org/W2321746654","doi":"https://doi.org/10.1007/s00262-016-1829-2","mag":"2321746654","pmid":"https://pubmed.ncbi.nlm.nih.gov/27034234","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5035667"},"language":"en","primary_location":{"id":"doi:10.1007/s00262-016-1829-2","doi":"https://doi.org/10.1007/s00262-016-1829-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00262-016-1829-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00262-016-1829-2.pdf","source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2321746654"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s00262-016-1829-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110286676","display_name":"Cariad Chester","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Cariad Chester","raw_affiliation_strings":["Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford University, 269 Campus Drive, CCSR 1140, Stanford, CA, 94305-5151, USA. cchester@stanford.edu","Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, 94305, USA. cchester@stanford.edu","Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford University, 269 Campus Drive, CCSR 1140, Stanford, CA, 94305-5151, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford University, 269 Campus Drive, CCSR 1140, Stanford, CA, 94305-5151, USA. cchester@stanford.edu","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"raw_affiliation_string":"Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, 94305, USA. cchester@stanford.edu","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"raw_affiliation_string":"Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford University, 269 Campus Drive, CCSR 1140, Stanford, CA, 94305-5151, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081757147","display_name":"Siddhant S. Ambulkar","orcid":"https://orcid.org/0000-0002-8654-1072","observed_orcids":["https://orcid.org/0000-0002-8654-1072"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Siddhant Ambulkar","raw_affiliation_strings":["Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford University, 269 Campus Drive, CCSR 1140, Stanford, CA, 94305-5151, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford University, 269 Campus Drive, CCSR 1140, Stanford, CA, 94305-5151, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108298451","display_name":"Holbrook E K Kohrt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Holbrook E. Kohrt","raw_affiliation_strings":["Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford University, 269 Campus Drive, CCSR 1140, Stanford, CA, 94305-5151, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford University, 269 Campus Drive, CCSR 1140, Stanford, CA, 94305-5151, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5110286676"],"corresponding_institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"],"apc_list":{"value":4590,"currency":"USD","value_usd":4590},"apc_paid":{"value":4590,"currency":"USD","value_usd":4590},"fwci":8.4072,"has_fulltext":true,"cited_by_count":139,"citation_normalized_percentile":{"value":0.98662572,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"65","issue":"10","first_page":"1243","last_page":"1248"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/4-1bb","display_name":"4-1BB","score":0.9800000190734863},{"id":"https://openalex.org/keywords/agonistic-monoclonal-antibody","display_name":"agonistic monoclonal antibody","score":0.9599999785423279},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7900000214576721},{"id":"https://openalex.org/keywords/costimulation","display_name":"costimulation","score":0.7120000123977661},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.7760000228881836},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6079999804496765},{"id":"https://openalex.org/keywords/cd8-t-cells","display_name":"CD8+ T cells","score":0.9210000038146973},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.9900000095367432},{"id":"https://openalex.org/keywords/tnf-receptor-superfamily","display_name":"TNF receptor superfamily","score":0.8799999952316284},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6200000047683716},{"id":"https://openalex.org/keywords/immunotoxicity","display_name":"immunotoxicity","score":0.3100000023841858}],"concepts":[{"id":"https://openalex.org/C2780249625","wikidata":"https://www.wikidata.org/wiki/Q14913226","display_name":"CD137","level":4,"score":0.8525393009185791},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6620780229568481},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5198003053665161},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4944422245025635},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.47389546036720276},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4568437337875366},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.45245301723480225},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.427821546792984},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.38133880496025085},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35434603691101074},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33770376443862915},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2552374303340912}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013602","descriptor_name":"T-Lymphocytes, Cytotoxic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D053261","descriptor_name":"Tumor Necrosis Factor Receptor Superfamily, Member 9","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D053261","descriptor_name":"Tumor Necrosis Factor Receptor Superfamily, Member 9","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1007/s00262-016-1829-2","doi":"https://doi.org/10.1007/s00262-016-1829-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00262-016-1829-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00262-016-1829-2.pdf","source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4011748","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5035667","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5035667","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5035667/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunol Immunother","raw_type":"Text"},{"id":"pmid:27034234","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27034234","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer immunology, immunotherapy : CII","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s00262-016-1829-2","doi":"https://doi.org/10.1007/s00262-016-1829-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s00262-016-1829-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s00262-016-1829-2.pdf","source":{"id":"https://openalex.org/S203303425","display_name":"Cancer Immunology Immunotherapy","issn_l":"0340-7004","issn":["0340-7004","1432-0851"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Immunology, Immunotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2321746654.pdf","grobid_xml":"https://content.openalex.org/works/W2321746654.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W1491394604","https://openalex.org/W1512799118","https://openalex.org/W1529424687","https://openalex.org/W1560312836","https://openalex.org/W1601495799","https://openalex.org/W1830102914","https://openalex.org/W1900170106","https://openalex.org/W1951679451","https://openalex.org/W1975060729","https://openalex.org/W1990948095","https://openalex.org/W1992546156","https://openalex.org/W1998006783","https://openalex.org/W2003896199","https://openalex.org/W2011435623","https://openalex.org/W2026238666","https://openalex.org/W2028582857","https://openalex.org/W2070059266","https://openalex.org/W2071144245","https://openalex.org/W2075840867","https://openalex.org/W2090191120","https://openalex.org/W2092972513","https://openalex.org/W2095543805","https://openalex.org/W2096738490","https://openalex.org/W2099241614","https://openalex.org/W2101538692","https://openalex.org/W2109490990","https://openalex.org/W2113170011","https://openalex.org/W2119139416","https://openalex.org/W2123658235","https://openalex.org/W2127735232","https://openalex.org/W2130579933","https://openalex.org/W2131131389","https://openalex.org/W2138062457","https://openalex.org/W2142943268","https://openalex.org/W2153519961","https://openalex.org/W2157798716","https://openalex.org/W2163196794","https://openalex.org/W2164720040","https://openalex.org/W2468502134","https://openalex.org/W2590243985"],"related_works":["https://openalex.org/W1512799118","https://openalex.org/W2136890067","https://openalex.org/W2767731416","https://openalex.org/W3032418194","https://openalex.org/W3176093962","https://openalex.org/W2106302477","https://openalex.org/W7066620649","https://openalex.org/W4385984212","https://openalex.org/W4383874168","https://openalex.org/W4295591182"],"abstract_inverted_index":{"The":[0],"success":[1],"of":[2,13,27,35,86,149,163],"checkpoint":[3],"inhibitors":[4],"has":[5,110],"validated":[6],"immunomodulatory":[7],"agents":[8,88],"as":[9],"a":[10,25,99,119,156],"valuable":[11],"class":[12],"anticancer":[14],"therapeutics.":[15],"A":[16],"promising":[17],"co-stimulatory":[18],"immunologic":[19],"target":[20],"is":[21,98],"4-1BB,":[22],"or":[23],"CD137,":[24],"member":[26],"the":[28,111,124,133,146,161],"tumor":[29,75],"necrosis":[30],"factor":[31],"receptor":[32],"superfamily.":[33],"Ligation":[34],"4-1BB":[36,62,104,150],"induces":[37],"an":[38],"activating":[39],"signal":[40],"in":[41,50,73,159],"CD8(+)":[42],"T":[43],"cells":[44],"and":[45,57,130],"natural":[46],"killer":[47],"cells,":[48],"resulting":[49],"increased":[51],"pro-inflammatory":[52],"cytokine":[53],"secretion,":[54],"cytolytic":[55],"function,":[56],"antibody-dependent":[58],"cell-mediated":[59],"cytotoxicity.":[60],"Targeting":[61],"with":[63],"agonistic":[64],"monoclonal":[65],"antibody":[66],"(mAb)":[67],"therapy":[68],"demonstrated":[69],"potent":[70],"antitumor":[71,115],"effects":[72],"murine":[74],"models.":[76],"While":[77,137],"anti-4-1BB":[78],"mAbs":[79],"have":[80],"entered":[81],"clinical":[82],"trials,":[83],"optimal":[84],"efficacy":[85],"4-1BB-targeted":[87],"will":[89],"inevitably":[90],"come":[91],"from":[92],"combination":[93,101,165],"therapeutic":[94],"strategies.":[95],"Checkpoint":[96],"blockade":[97],"compelling":[100],"partner":[102],"for":[103],"agonism.":[105],"This":[106],"novel":[107],"immunotherapeutic":[108],"approach":[109],"potential":[112],"to":[113,143],"active":[114],"immune":[116],"effectors":[117],"by":[118],"complementary":[120],"mechanism:":[121],"simultaneously":[122],"\"removing":[123],"brakes\"":[125],"via":[126,135],"blocking":[127],"inhibitory":[128],"signaling":[129],"\"stepping":[131],"on":[132],"accelerator\"":[134],"co-stimulation.":[136],"important":[138],"considerations":[139],"should":[140],"be":[141],"given":[142],"4-1BB-mediated":[144],"toxicities,":[145],"current":[147],"understanding":[148],"biology":[151],"suggests":[152],"it":[153],"may":[154],"play":[155],"key":[157],"role":[158],"advancing":[160],"capabilities":[162],"cancer":[164],"therapy.":[166]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2321746654","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":17},{"year":2019,"cited_by_count":18},{"year":2018,"cited_by_count":18},{"year":2017,"cited_by_count":18},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
